With $50M from Flagship Pioneering, Serif strives to write new chapter for DNA medicines
With $50M from Flagship Pioneering, Serif strives to write new chapter for DNA medicines
With $50M from Flagship Pioneering, Serif strives to write new chapter for DNA medicines
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.